Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy.

Alzheimer's & dementia (New York, N. Y.)

Landen JW, Cohen S, Billing CB, Cronenberger C, Styren S, Burstein AH, Sattler C, Lee JH, Jack CR, Kantarci K, Schwartz PF, Duggan WT, Zhao Q, Sprenger K, Bednar MM, Binneman B.
PMID: 29067341
Alzheimers Dement (N Y). 2017 May 10;3(3):339-347. doi: 10.1016/j.trci.2017.04.003. eCollection 2017 Sep.

INTRODUCTION: Multiple intravenous doses of ponezumab, an anti-amyloid antibody, were evaluated in subjects with mild-to-moderate Alzheimer's disease (AD).METHODS: In part A, 77 subjects were randomized to ponezumab 0.1, 0.5, or 1 mg/kg (75 treated) and 26 to placebo (24...

Cite
Landen JW, Cohen S, Billing CB, et al. Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy. Alzheimers Dement (N Y). 2017;3(3):339-347doi: 10.1016/j.trci.2017.04.003.
Landen, J. W., Cohen, S., Billing, C. B., Cronenberger, C., Styren, S., Burstein, A. H., Sattler, C., Lee, J. H., Jack, C. R., Kantarci, K., Schwartz, P. F., Duggan, W. T., Zhao, Q., Sprenger, K., Bednar, M. M., & Binneman, B. (2017). Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy. Alzheimer's & dementia (New York, N. Y.), 3(3), 339-347. https://doi.org/10.1016/j.trci.2017.04.003
Landen, Jaren W, et al. "Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy." Alzheimer's & dementia (New York, N. Y.) vol. 3,3 (2017): 339-347. doi: https://doi.org/10.1016/j.trci.2017.04.003
Landen JW, Cohen S, Billing CB, Cronenberger C, Styren S, Burstein AH, Sattler C, Lee JH, Jack CR, Kantarci K, Schwartz PF, Duggan WT, Zhao Q, Sprenger K, Bednar MM, Binneman B. Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy. Alzheimers Dement (N Y). 2017 May 10;3(3):339-347. doi: 10.1016/j.trci.2017.04.003. eCollection 2017 Sep. PMID: 29067341; PMCID: PMC5651443.
Copy Download .nbib Format: NLM
Brazilian caregivers' conception on child bullying.

Psicologia, reflexao e critica : revista semestral do Departamento de Psicologia da UFRGS

Akerman L, Borsa JC, Landim I, Bienemann B.
PMID: 32026987
Psicol Reflex Crit. 2018 Nov 26;31(1):31. doi: 10.1186/s41155-018-0113-0.

BACKGROUND: Bullying is a complex social phenomenon, which is common in peer relationships and is influenced by different individual and contextual characteristics. Despite broad knowledge on the importance of the family for children's development, many studies about bullying neglect...

Cite
Akerman L, Borsa JC, Landim I, et al. Brazilian caregivers' conception on child bullying. Psicol Reflex Crit. 2018;31(1):31doi: 10.1186/s41155-018-0113-0.
Akerman, L., Borsa, J. C., Landim, I., & Bienemann, B. (2018). Brazilian caregivers' conception on child bullying. Psicologia, reflexao e critica : revista semestral do Departamento de Psicologia da UFRGS, 31(1), 31. https://doi.org/10.1186/s41155-018-0113-0
Akerman, Laila, et al. "Brazilian caregivers' conception on child bullying." Psicologia, reflexao e critica : revista semestral do Departamento de Psicologia da UFRGS vol. 31,1 (2018): 31. doi: https://doi.org/10.1186/s41155-018-0113-0
Akerman L, Borsa JC, Landim I, Bienemann B. Brazilian caregivers' conception on child bullying. Psicol Reflex Crit. 2018 Nov 26;31(1):31. doi: 10.1186/s41155-018-0113-0. PMID: 32026987; PMCID: PMC6967208.
Copy Download .nbib Format: NLM
Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study.

Alzheimer's & dementia (New York, N. Y.)

Landen JW, Andreasen N, Cronenberger CL, Schwartz PF, Börjesson-Hanson A, Östlund H, Sattler CA, Binneman B, Bednar MM.
PMID: 29067345
Alzheimers Dement (N Y). 2017 Jun 08;3(3):393-401. doi: 10.1016/j.trci.2017.05.003. eCollection 2017 Sep.

INTRODUCTION: The safety, pharmacokinetics, and effect on peripheral and central amyloid β (Aβ) of multiple doses of ponezumab, an anti-Aβ monoclonal antibody, were characterized in subjects with mild-to-moderate Alzheimer's disease treated for 1 year.METHODS: Subjects were aged ≥50 years...

Cite
Landen JW, Andreasen N, Cronenberger CL, et al. Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study. Alzheimers Dement (N Y). 2017;3(3):393-401doi: 10.1016/j.trci.2017.05.003.
Landen, J. W., Andreasen, N., Cronenberger, C. L., Schwartz, P. F., Börjesson-Hanson, A., Östlund, H., Sattler, C. A., Binneman, B., & Bednar, M. M. (2017). Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study. Alzheimer's & dementia (New York, N. Y.), 3(3), 393-401. https://doi.org/10.1016/j.trci.2017.05.003
Landen, Jaren W, et al. "Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study." Alzheimer's & dementia (New York, N. Y.) vol. 3,3 (2017): 393-401. doi: https://doi.org/10.1016/j.trci.2017.05.003
Landen JW, Andreasen N, Cronenberger CL, Schwartz PF, Börjesson-Hanson A, Östlund H, Sattler CA, Binneman B, Bednar MM. Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study. Alzheimers Dement (N Y). 2017 Jun 08;3(3):393-401. doi: 10.1016/j.trci.2017.05.003. eCollection 2017 Sep. PMID: 29067345; PMCID: PMC5651442.
Copy Download .nbib Format: NLM
Genetic mapping and phenotypic analysis of .

microPublication biology

Talley EM, Watts CT, Aboyer S, Adamson MG, Akoto HA, Altemus H, Avella PJ, Bailey R, Bell ER, Bell KL, Breneman K, Burkhart JS, Chanley LJ, Cook SS, DesLaurier MT, Dorsey TR, Doyle CJ, Egloff ME, Fasawe AS, Garcia KK, Graves NP, Gray TK, Gustafson EM, Hall MJ, Hayes JD, Holic LJ, Jarvis BA, Klos PS, Kritzmire S, Kuzovko L, Lainez E, McCoy S, Mierendorf JC, Neri NA, Neville CR, Osborn K, Parker K, Parks ME, Peck K, Pitt R, Platta ME, Powell B, Rodriguez K, Ruiz C, Schaefer MN, Shields AB, Smiley JB, Stauffer B, Straub D, Sweeney JL, Termine KM, Thomas B, Toth SD, Veile TR, Walker KS, Webster PN, Woodard BJ, Yoder QL, Young MK, Zeedyk ML, Ziegler LN, Bieser KL, Puthoff DP, Stamm J, Vrailas-Mortimer AD, Kagey JD, Merkle JA.
PMID: 34278244
MicroPubl Biol. 2021 Jul 13;2021. doi: 10.17912/micropub.biology.000418. eCollection 2021.

Genetic screens are used to identify genes involved in specific biological processes. An EMS mutagenesis screen in

Cite
Talley EM, Watts CT, Aboyer S, et al. Genetic mapping and phenotypic analysis of . MicroPubl Biol. 2021;2021doi: 10.17912/micropub.biology.000418.
Talley, E. M., Watts, C. T., Aboyer, S., Adamson, M. G., Akoto, H. A., Altemus, H., Avella, P. J., Bailey, R., Bell, E. R., Bell, K. L., Breneman, K., Burkhart, J. S., Chanley, L. J., Cook, S. S., DesLaurier, M. T., Dorsey, T. R., Doyle, C. J., Egloff, M. E., Fasawe, A. S., Garcia, K. K., Graves, N. P., Gray, T. K., Gustafson, E. M., Hall, M. J., Hayes, J. D., Holic, L. J., Jarvis, B. A., Klos, P. S., Kritzmire, S., Kuzovko, L., Lainez, E., McCoy, S., Mierendorf, J. C., Neri, N. A., Neville, C. R., Osborn, K., Parker, K., Parks, M. E., Peck, K., Pitt, R., Platta, M. E., Powell, B., Rodriguez, K., Ruiz, C., Schaefer, M. N., Shields, A. B., Smiley, J. B., Stauffer, B., Straub, D., Sweeney, J. L., Termine, K. M., Thomas, B., Toth, S. D., Veile, T. R., Walker, K. S., Webster, P. N., Woodard, B. J., Yoder, Q. L., Young, M. K., Zeedyk, M. L., Ziegler, L. N., Bieser, K. L., Puthoff, D. P., Stamm, J., Vrailas-Mortimer, A. D., Kagey, J. D., & Merkle, J. A. (2021). Genetic mapping and phenotypic analysis of . microPublication biology, 2021. https://doi.org/10.17912/micropub.biology.000418
Talley, Elyse M, et al. "Genetic mapping and phenotypic analysis of ." microPublication biology vol. 2021 (2021). doi: https://doi.org/10.17912/micropub.biology.000418
Talley EM, Watts CT, Aboyer S, Adamson MG, Akoto HA, Altemus H, Avella PJ, Bailey R, Bell ER, Bell KL, Breneman K, Burkhart JS, Chanley LJ, Cook SS, DesLaurier MT, Dorsey TR, Doyle CJ, Egloff ME, Fasawe AS, Garcia KK, Graves NP, Gray TK, Gustafson EM, Hall MJ, Hayes JD, Holic LJ, Jarvis BA, Klos PS, Kritzmire S, Kuzovko L, Lainez E, McCoy S, Mierendorf JC, Neri NA, Neville CR, Osborn K, Parker K, Parks ME, Peck K, Pitt R, Platta ME, Powell B, Rodriguez K, Ruiz C, Schaefer MN, Shields AB, Smiley JB, Stauffer B, Straub D, Sweeney JL, Termine KM, Thomas B, Toth SD, Veile TR, Walker KS, Webster PN, Woodard BJ, Yoder QL, Young MK, Zeedyk ML, Ziegler LN, Bieser KL, Puthoff DP, Stamm J, Vrailas-Mortimer AD, Kagey JD, Merkle JA. Genetic mapping and phenotypic analysis of . MicroPubl Biol. 2021 Jul 13;2021. doi: 10.17912/micropub.biology.000418. eCollection 2021. PMID: 34278244; PMCID: PMC8278230.
Copy Download .nbib Format: NLM
Resonance Energy Transfer Between Luminescent Quantum Dots and Diverse Fluorescent Protein Acceptors.

The journal of physical chemistry. C, Nanomaterials and interfaces

Medintz IL, Pons T, Susumu K, Boeneman K, Dennis A, Farrell D, Deschamps JR, Melinger JS, Bao G, Mattoussi H.
PMID: 20161358
J Phys Chem C Nanomater Interfaces. 2009 Oct 05;113(43):18552-18561. doi: 10.1021/jp9060329.

We characterized the resonance energy transfer interactions for conjugates consisting of QD donors self-assembled with three distinct fluorescent protein acceptors: two monomeric fluorescent proteins, the dsRed derivative mCherry or yellow fluorescent protein and the multi-chromophore b-phycoerythrin light harvesting complex....

Cite
Medintz IL, Pons T, Susumu K, et al. Resonance Energy Transfer Between Luminescent Quantum Dots and Diverse Fluorescent Protein Acceptors. J Phys Chem C Nanomater Interfaces. 2009;113(43):18552-18561doi: 10.1021/jp9060329.
Medintz, I. L., Pons, T., Susumu, K., Boeneman, K., Dennis, A., Farrell, D., Deschamps, J. R., Melinger, J. S., Bao, G., & Mattoussi, H. (2009). Resonance Energy Transfer Between Luminescent Quantum Dots and Diverse Fluorescent Protein Acceptors. The journal of physical chemistry. C, Nanomaterials and interfaces, 113(43), 18552-18561. https://doi.org/10.1021/jp9060329
Medintz, Igor L, et al. "Resonance Energy Transfer Between Luminescent Quantum Dots and Diverse Fluorescent Protein Acceptors." The journal of physical chemistry. C, Nanomaterials and interfaces vol. 113,43 (2009): 18552-18561. doi: https://doi.org/10.1021/jp9060329
Medintz IL, Pons T, Susumu K, Boeneman K, Dennis A, Farrell D, Deschamps JR, Melinger JS, Bao G, Mattoussi H. Resonance Energy Transfer Between Luminescent Quantum Dots and Diverse Fluorescent Protein Acceptors. J Phys Chem C Nanomater Interfaces. 2009 Oct 05;113(43):18552-18561. doi: 10.1021/jp9060329. PMID: 20161358; PMCID: PMC2777665.
Copy Download .nbib Format: NLM
Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder.

Innovations in clinical neuroscience

Targum SD, Murphy C, Khan J, Zumpano L, Whitlock M, Simen AA, Binneman B.
PMID: 29721364
Innov Clin Neurosci. 2018 Apr 01;15(3):37-42.

No abstract available.

Cite
Targum SD, Murphy C, Khan J, et al. Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder. Innov Clin Neurosci. 2018;15(3):37-42
Targum, S. D., Murphy, C., Khan, J., Zumpano, L., Whitlock, M., Simen, A. A., & Binneman, B. (2018). Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder. Innovations in clinical neuroscience, 15(3), 37-42.
Targum, Steven D, et al. "Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder." Innovations in clinical neuroscience vol. 15,3 (2018): 37-42.
Targum SD, Murphy C, Khan J, Zumpano L, Whitlock M, Simen AA, Binneman B. Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder. Innov Clin Neurosci. 2018 Apr 01;15(3):37-42. PMID: 29721364; PMCID: PMC5919431.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries